EUVIMEDEUVIMED entdecken
Crossref

In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius

Mattia Pirolo iD, Mareliza Menezes, Peter Damborg, Alice Wegener, Birgitta Duim, Els Broens iD, Lisbeth Rem Jessen, Mette Schjærff, Luca Guardabassi

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Mattia Pirolo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark. Hauptthemen laut MEDLINE: Staphylococcal Infections, Dog Diseases, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Agria and SKK Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) lineages harbouring staphylococcal cassette chromosome (SCC) mec types IV, V and ΨSCCmec57395 usually display low oxacillin MICs (0.5–2 mg/L).

Objectives

To evaluate how oxacillin MICs correlate with PBP mutations and susceptibility to β-lactams approved for veterinary use.

Methods

Associations between MICs and PBP mutations were investigated by broth microdilution, time–kill and genome sequence analyses in 117 canine MRSP strains harbouring these SCCmec types. Clinical outcome was retrospectively evaluated in 11 MRSP-infected dogs treated with β-lactams.

Results

Low-level MRSP was defined by an oxacillin MIC <4 mg/L. Regardless of strain genotype, all low-level MRSP isolates (n = 89) were cefalexin susceptible, whereas no strains were amoxicillin/clavulanate susceptible according to clinical breakpoints. Exposure to 2× MIC of cefalexin resulted in complete killing within 8 h. High (≥4 mg/L) oxacillin MICs were associated with substitutions in native PBP2, PBP3, PBP4 and acquired PBP2a, one of which (V390M in PBP3) was statistically significant by multivariable modelling. Eight of 11 dogs responded to systemic therapy with first-generation cephalosporins (n = 4) or amoxicillin/clavulanate (n = 4) alone or with concurrent topical treatment, including 6 of 7 dogs infected with low-level MRSP.

Conclusions

Oxacillin MIC variability in MRSP is influenced by mutations in multiple PBPs and correlates with cefalexin susceptibility. The expert rule recommending that strains with oxacillin MIC ≥0.5 mg/L are reported as resistant to all β-lactams should be reassessed based on these results, which are highly clinically relevant in light of the shortage of effective antimicrobials for systemic treatment of MRSP infections in veterinary medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal InfectionsDog DiseasesMethicillin-Resistant Staphylococcus aureusDogsAnti-Bacterial AgentsCephalexinMicrobial Sensitivity TestsAnimalsRetrospective StudiesOxacillinMethicillin ResistanceAmoxicillin-Potassium Clavulanate CombinationStaphylococcus

Substanzen

CephalexinOxacillinAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
  • Department of Biomolecular Health Sciences, Division of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.

ORCID-Profile: Mattia Pirolo, Els Broens

Förderung

  • Agria and SKK Research Fund

Zitieren

APA

Pirolo, M., Menezes, M., Damborg, P., Wegener, A., Duim, B., Broens, E., Jessen, L. R., Schjærff, M., & Guardabassi, L. (2023). In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad182

Vancouver

Pirolo M, Menezes M, Damborg P, Wegener A, Duim B, Broens E, et al. In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad182

BibTeX
@article{Pirolo2023,
  author = {Pirolo, Mattia and Menezes, Mareliza and Damborg, Peter and Wegener, Alice and Duim, Birgitta and Broens, Els and Jessen, Lisbeth Rem and Schjærff, Mette and Guardabassi, Luca},
  title = {In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad182}
}
Kostenlos starten →